Ireland
--:--IST
Starting soon Observational

Evaluation of Atherectomy in the Management of Occlusive Lesions of the Common Femoral Arteries

NCT07142330 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2025-09-01
Last updated
2025-08-26

Condition(s) studied

Femoral Artery OcclusionAtheromatous Plaques

Investigational drug(s) / intervention(s)

Atherectomy

Atherectomy: Two different techniques : rotational atherectomy or thromboendarterectomy

Study summary

Thromboendarterectomy is the standard technique for the treatment of symptomatic occlusive lesions of the common femoral artery. It consists of surgically controlling the artery and interrupting circulation, opening the vessel and removing the atherosclerotic plaque. However, this technique is associated with healing difficulties, postoperative infections, and debilitating incisional pain. The rise of endovascular therapies, particularly at the coronary level, has led to the emergence of new deocclusion techniques, including rotational atherectomy. This technique relies on the use of an intravascular catheter that reams out the atherosclerotic plaque while re-aspirating the resulting debris. A few studies have examined the use of rotational atherectomy for occlusive lesions of the common femoral arteries, but have not evaluated its results compared to the standard treatment. The aim of this multicenter cohort is to describe the efficacy and safety of rotational atherectomy and the standard treatment, thromboendarterectomy, in symptomatic occlusive lesions affecting the common femoral artery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Male or female patient over 18 years of age * Non-emergency * Claudicating patient with significant de novo calcified stenosis affecting the common femoral artery, technically eligible for revascularization by thromboendarterectomy or rotational atherectomy * Surgery planned with either technique * Patient's consent to participate in the study must be obtained, Exclusion Criteria: * Patient contraindicated for either technique (for surgical or anesthesiological reasons) * Patient with asymptomatic lesions of the common femoral artery * Patient with a history of surgery or angioplasty/stenting of the femoral stump * Patient with occlusion of the ipsilateral common femoral artery or external iliac artery * Patient with an indication for additional aortofemoral, iliofemoral, femoral-popliteal, or hamstring bypass * Patient with severe trophic disorders for which a major amputation is considered immediately in addition to revascularization * Patient objecting to the use of their data

Primary outcome measure(s)

  • Local complications — one month
    Local complications are defined as follows: hematoma, active bleeding, local infection, thrombosis, delayed healing, false aneurysm, arteriovenous fistula, and neuropathic pain following surgical trauma.

Trial sites (1)

FacilityCityRegionStatus
Hôpital Privé de Villeneuve d'Ascq, Villeneuve-d'Ascq France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07142330 on ClinicalTrials.gov ↗ ← All trials in France